Literature DB >> 7244055

Hormones, dopamine receptors and schizophrenia.

H Y Meltzer, D Busch, V S Fang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7244055     DOI： 10.1016/0306-4530(81)90045-7

Source DB:  PubMed          Journal:  Psychoneuroendocrinology        ISSN： 0306-4530            Impact factor:   4.905


× No keyword cloud information.
  4 in total

1.  Reduced growth hormone response to apomorphine in schizophrenic patients with poor premorbid social functioning.

Authors:  K L Malas; D P van Kammen; E A de Fraites; G M Brown; P W Gold
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

2.  Neuroendocrine effects of apomorphine in chronic schizophrenic patients under long-term neuroleptic therapy and after drug withdrawal: relations to psychopathology and tardive dyskinesia.

Authors:  F Müller-Spahn; M Ackenheil; M Albus; G May; D Naber; D Welter; K Zander
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Plasma growth hormone response to oral l-dopa in infantile autism.

Authors:  S I Deutsch; M Campbell; E J Sachar; W H Green; R David
Journal:  J Autism Dev Disord       Date:  1985-06

4.  Responses of prolactin and growth hormone to L-tryptophan infusion: effects in normal subjects and schizophrenic patients receiving neuroleptics.

Authors:  P J Cowen; H Gadhvi; B Gosden; T Kolakowska
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.